Cargando…
An Evidence-Based Review of Alternating Electric Fields Therapy for Malignant Gliomas
Glioblastoma is a deadly disease and even aggressive neurosurgical resection followed by radiation and chemotherapy only extends patient survival to a median of 1.5 years. The challenge in treating this type of tumor stems from the rapid proliferation of the malignant glioma cells, the diffuse infil...
Autores principales: | Wong, Eric T, Lok, Edwin, Swanson, Kenneth D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491358/ https://www.ncbi.nlm.nih.gov/pubmed/26143265 http://dx.doi.org/10.1007/s11864-015-0353-5 |
Ejemplares similares
-
Tumor Treating Fields in the Management of Patients with Malignant Gliomas
por: Ghiaseddin, Ashley P., et al.
Publicado: (2020) -
An Overview of Alternating Electric Fields Therapy (NovoTTF Therapy) for the Treatment of Malignant Glioma
por: Swanson, Kenneth D., et al.
Publicado: (2016) -
Recent Advances in Treatment of Primary Central Nervous System Lymphoma
por: Nayak, Lakshmi, et al.
Publicado: (2013) -
Current State of Immunotherapy for Treatment of Glioblastoma
por: McGranahan, Tresa, et al.
Publicado: (2019) -
Clinical Trial Considerations in Neuro-oncology
por: Lee, Eudocia Q.
Publicado: (2021)